论文部分内容阅读
急性脑梗死是常见病、高发病,给家庭及社会造成严重的负担,针对急性脑梗死的治疗方法较多,但疗效不一。本院神经内科于2007年10月至2009年2月在应用舒血宁的基础上加用依达拉奉联合治疗急性脑梗死82例,与单用舒血宁治疗进行临床比较,取得了较好的临床疗效,现报告如下。1临床资
Acute cerebral infarction is a common disease, high incidence, to the family and society a serious burden on the treatment of acute cerebral infarction more, but the effect is different. Neurology in our hospital from October 2007 to February 2009 in the application of Shuxuening based edara combined with edaravone combined treatment of 82 cases of acute cerebral infarction, and Shuxuening single clinical comparison achieved more than Good clinical efficacy, are as follows. 1 clinical resources